Zepbound leads to more weight loss than Wegovy, Eli Lilly says
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than Wegovy, a drug with the main active ingredient semaglutide, according to new data released Wednesday by Eli Lilly, the maker of Zepbound.
18hOpinion
Ozempic and Wegovy might be making it harder for physicians to guide patients toward lifestyle changes − the real key to long ...
Researchers have developed and are testing a small, implanted gastric balloon that people can inflate or deflate to feel full ...
Ozempic, Wegovy, and other weight-loss drugs could make millions healthier, but access and affordability barriers abound. Here's how we reported it.
State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...
About one-third of U.S. adults without diabetes who are eligible for weight loss treatment with glucagon-like peptide 1 ...
6don MSN
North Carolina stopped covering weight loss drugs such as Ozempic for state employees without diabetes. But it extended ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback